Literature DB >> 12072308

Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease.

P-T T Pham1, A H Wilkinson, H A Gritsch, P C T Pham, J M Miller, C R Lassman, G M Danovitch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12072308     DOI： 10.1016/s0041-1345(02)02754-9

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Epstein-Barr virus-associated Hodgkin's disease following renal transplantation.

Authors:  Jung-Hye Choi; Myung-Ju Ahn; Young-Ha Oh; Sang-Woong Han; Ho-Jung Kim; Young-Yeul Lee; In-Soon Kim
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

Review 2.  Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens.

Authors:  Vidhya Murukesan; Sandeep Mukherjee
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

Review 3.  Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.

Authors:  Luis de la Cruz-Merino; Marylène Lejeune; Esteban Nogales Fernández; Fernando Henao Carrasco; Ana Grueso López; Ana Illescas Vacas; Mariano Provencio Pulla; Cristina Callau; Tomás Álvaro
Journal:  Clin Dev Immunol       Date:  2012-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.